FDA · Class II · August 26, 2026

Siemens Healthcare Diagnostics recall: Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL and 1 more product

Siemens Healthcare Diagnostics, Inc. is recalling Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL and 1 more product – 20 units; 55 units. The U.S. Food and Drug Administration published the recall on August 26, 2026; it began on July 13, 2026. Distributed nationwide.

Serious Class II means the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

An FDA laboratory that tests medical devices
Illustration: An FDA laboratory that tests medical devices – not the recalled product. Photo: U.S. Food and Drug Administration, public domain.
ProductSyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL and 1 more product
BrandSiemens Healthcare Diagnostics
CompanySiemens Healthcare Diagnostics, Inc.
TypeMedical devices
ClassificationClass II
Recall dateJuly 13, 2026
Published by FDAAugust 26, 2026
Quantity20 units; 55 units
Recall ID99446
As listed by FDA

Recalled products (2)

  1. Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL
    FDA recall number
    Z-2975-2026
    Codes, lots and dates
    Lot U1/UDI: 00842768001048
    Quantity
    20 units
    Classification
    Class II
  2. Beckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mL
    FDA recall number
    Z-2976-2026
    Codes, lots and dates
    Lots: 2597, 2627, 2709/UDI: 00842768023293
    Quantity
    55 units
    Classification
    Class II
Exactly as the agency lists them

Identifiers and details

FDA event ID
99446
Initiated
Voluntary: Firm initiated
Status
Ongoing
Firm location
East Walpole, MA, United States

Why it was recalled

The reason the FDA lists: “Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential life-threatening cardiac arrhythmias or inadequate antimalarial therapy.”

Where it was sold

Nationwide. Distribution as the FDA records it: “Worldwide - US Nationwide distribution in the state of CA and the country of Italy.”

What to do

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Official notice: FDA Enforcement Report record (event 99446, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.

Same brand

Other Siemens Healthcare Diagnostics recalls

DateRecallProblemAgency
Oct 7, 2026Siemens Healthcare Diagnostics recall: Atellica CH Revised C-Reactive ProteinMedical devices · 42940 units (3938 US, 39002 OUS)The potential for falsely elevated results.
Serious
FDA
Class II
Latest

Other medical device recalls

DateRecallProblemAgency
Oct 7, 2026Draeger recall: VentStar Resus NeoMedical devices · 1,063,643 unitsPotential cracks in the hose, which could lead to leakage or the hose falling off.
Most serious
FDA
Class I
Oct 7, 2026Medline Industries recall: Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories and 1 more productMedical devices · 771,127 totala fire hazard
Most serious
FDA
Class I
Oct 7, 2026Karl Storz Endoscopy recall: HOPKINS Telescope 30¿Medical devices · 6 eyepiecesDue to incorrect inside packaging label for eyepiece.
Serious
FDA
Class II
Oct 7, 2026Noxbox recall: NOxBOXi Nitric Oxide Delivery SystemMedical devices · 1,667 unitsPotential for irregular oxygen readings due to a manufacturing issue affecting certain oxy…
Serious
FDA
Class II
Oct 7, 2026Tandem Diabetes Care recall: T:slim Mobile ApplicationMedical devices · 177A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a sof…
Serious
FDA
Class II
Oct 7, 2026Beckman Coulter Mishima K.K recall: Systems/units containing affected software/SQL BECKMAN COULTER CHEMISTRY ANALYZER AU480…Medical devices · 492 unitsCertain AU480 chemistry analyzers, with Windows 10 IoT Enterprise 2021 LTSC PCs, may outpu…
Serious
FDA
Class II
FAQ

About this recall

Is Siemens Healthcare Diagnostics Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL recalled?

Yes. Siemens Healthcare Diagnostics, Inc. recalled it on July 13, 2026; FDA published it August 26, 2026 (Class II). Only the lots, dates or models listed on this page are included.

Why was it recalled?

Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential life-threatening cardiac arrhythmias or inadequate antimalarial therapy.

What should I do if I have it?

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Where was it sold?

Nationwide.

Recalls

More recalls

Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.

Cookies

We measure traffic so we know which stories you care about. You can change your choice at any time.